Your browser doesn't support javascript.
loading
An In-Depth Evaluation of the Validity and Logistics Surrounding the Testing of AR-V7 mRNA Expression in Circulating Tumor Cells.
Sieuwerts, Anieta M; Mostert, Bianca; van der Vlugt-Daane, Michelle; Kraan, Jaco; Beaufort, Corine M; Van, Mai; Prager, Wendy J C; De Laere, Bram; Beije, Nick; Hamberg, Paul; Westgeest, Hans M; Tascilar, Metin; Dirix, Luc Y; Onstenk, Wendy; de Wit, Ronald; Lolkema, Martijn P; Mathijssen, Ron H J; Martens, John W M; Sleijfer, Stefan.
Afiliação
  • Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands. Electronic address: a.sieuwerts@erasmusmc.nl.
  • Mostert B; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands.
  • van der Vlugt-Daane M; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands.
  • Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands.
  • Beaufort CM; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands.
  • Van M; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands.
  • Prager WJC; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands.
  • De Laere B; Department of Oncological Research, GZA Hospitals Sint-Augustinus, Wilrijk, Belgium; Center for Oncological Research, University of Antwerp, Antwerp, Belgium.
  • Beije N; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands.
  • Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
  • Westgeest HM; Department of Internal Medicine, Amphia Ziekenhuis, Breda, the Netherlands.
  • Tascilar M; Department of Internal Medicine, Isala Ziekenhuis, Zwolle, the Netherlands.
  • Dirix LY; Department of Oncological Research, GZA Hospitals Sint-Augustinus, Wilrijk, Belgium; Center for Oncological Research, University of Antwerp, Antwerp, Belgium.
  • Onstenk W; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands.
  • de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands.
  • Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands.
  • Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands.
  • Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands.
  • Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands.
J Mol Diagn ; 20(3): 316-325, 2018 05.
Article em En | MEDLINE | ID: mdl-29474983

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Genética / RNA Mensageiro / Receptores Androgênicos / Regulação Neoplásica da Expressão Gênica / Células Neoplásicas Circulantes Tipo de estudo: Clinical_trials / Evaluation_studies Limite: Humans Idioma: En Revista: J Mol Diagn Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Genética / RNA Mensageiro / Receptores Androgênicos / Regulação Neoplásica da Expressão Gênica / Células Neoplásicas Circulantes Tipo de estudo: Clinical_trials / Evaluation_studies Limite: Humans Idioma: En Revista: J Mol Diagn Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2018 Tipo de documento: Article